Phase II Trial of Pembrolizumab for Advanced Penile Squamous Cell Carcinoma Following Previous Chemotherapy
Phase of Trial: Phase II
Latest Information Update: 24 May 2017
At a glance
- Drugs Pembrolizumab (Primary)
- Indications Penile cancer; Squamous cell cancer
- Focus Therapeutic Use
- 28 Dec 2016 Planned primary completion date changed from 1 Jul 2019 to 1 Oct 2019.
- 28 Dec 2016 Status changed from not yet recruiting to recruiting.
- 22 Jul 2016 New trial record